Export 8 results:
Author [ Title(Asc)] Type Year
Filters: Author is Richie, Thomas L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
S. A. Jongo, Church, L. W. Preston, Mtoro, A. T., Chakravarty, S., Ruben, A. J., Swanson, P. A., Kassim, K. R., Mpina, M., Tumbo, A. - M., Milando, F. A., Qassim, M., Juma, O. A., Bakari, B. M., Simon, B., James, E. R., Abebe, Y., Kc, N., Saverino, E., Gondwe, L., Studer, F., Fink, M., Cosi, G., El-Khorazaty, J., Styers, D., Seder, R. A., Schindler, T., Billingsley, P. F., Daubenberger, C., B Sim, K. Lee, Tanner, M., Richie, T. L., Abdulla, S., and Hoffman, S. L., “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
P
R. A. Seder, Chang, L. - J., Enama, M. E., Zephir, K. L., Sarwar, U. N., Gordon, I. J., Holman, L. S. A., James, E. R., Billingsley, P. F., Gunasekera, A., Richman, A., Chakravarty, S., Manoj, A., Velmurugan, S., Li, M. L., Ruben, A. J., Li, T., Eappen, A. G., Stafford, R. E., Plummer, S. H., Hendel, C. S., Novik, L., Costner, P. J. M., Mendoza, F. H., Saunders, J. G., Nason, M. C., Richardson, J. H., Murphy, J., Davidson, S. A., Richie, T. L., Sedegah, M., Sutamihardja, A., Fahle, G. A., Lyke, K. E., Laurens, M. B., Roederer, M., Tewari, K., Epstein, J. E., B Sim, K. Lee, Ledgerwood, J. E., Graham, B. S., and Hoffman, S. L., “Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.”, Science, vol. 341, no. 6152, pp. 1359-65, 2013.
D. Coulibaly, Kone, A. K., Traore, K., Niangaly, A., Kouriba, B., Arama, C., Zeguime, A., Dolo, A., Lyke, K. E., Plowe, C. V., Abebe, Y., Potter, G. E., Kennedy, J. K., Galbiati, S. M., Nomicos, E., Deye, G. A., Richie, T. L., James, E. R., Kc, N., B Sim, K. Lee, Hoffman, S. L., Doumbo, O. K., Thera, M. A., and Laurens, M. B., “PfSPZ-CVac Malaria Vaccine Demonstrates Safety Among Malaria-experienced Adults: A Randomized, Controlled Phase 1 Trial”, EClinicalMedicine, vol. 52, p. 101579, 2022.
S. C. Murphy, Deye, G. A., B Sim, K. Lee, Galbiati, S., Kennedy, J. K., Cohen, K. W., Chakravarty, S., Kc, N., Abebe, Y., James, E. R., Kublin, J. G., Hoffman, S. L., Richie, T. L., and Jackson, L. A., “PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.”, PLoS Pathog, vol. 17, no. 5, p. e1009594, 2021.
D
M. B. Laurens, Berry, A. A., Travassos, M. A., Strauss, K., Adams, M., Shrestha, B., Li, T., Eappen, A., Manoj, A., Abebe, Y., Murshedkar, T., Gunasekera, A., Richie, T. L., Lyke, K. E., Plowe, C. V., Kennedy, J. K., Potter, G. E., Deye, G. A., Sim, B. K. L., and Hoffman, S. L., “Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults.”, J Infect Dis, vol. 220, no. 12, pp. 1962-1966, 2019.